FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

716125002: Pembrolizumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3304810011 Pembrolizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3304811010 Pembrolizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pembrolizumab (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Pembrolizumab (substance) Is a Monoclonal antibody agent false Inferred relationship Some
Pembrolizumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Pembrolizumab (substance) Is a Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) true Inferred relationship Some
Pembrolizumab (substance) Has disposition (attribute) Programmed cell death protein 1 inhibitor (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing pembrolizumab (medicinal product) Has active ingredient True Pembrolizumab (substance) Inferred relationship Some 1
Product containing pembrolizumab in parenteral dose form (medicinal product form) Has active ingredient True Pembrolizumab (substance) Inferred relationship Some 1
Product containing only pembrolizumab (medicinal product) Has active ingredient True Pembrolizumab (substance) Inferred relationship Some 1
Product containing only pembrolizumab in parenteral dose form (medicinal product form) Has active ingredient True Pembrolizumab (substance) Inferred relationship Some 1
Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Pembrolizumab (substance) Inferred relationship Some 1
Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Pembrolizumab (substance) Inferred relationship Some 1
Product containing precisely pembrolizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Pembrolizumab (substance) Inferred relationship Some 1
Product containing precisely pembrolizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Pembrolizumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start